National Eye Institute (NEI) clinical trials
Listed in the registry as: U.S. National Institutes of Health.
The registry lists 272 studies whose lead sponsor is National Eye Institute (NEI). 17 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the National Eye Institute (NEI) studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions National Eye Institute (NEI) leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 272. Browse all 272 →
- Visual Attention, Object Recognition, and Eye Movements in Healthy VolunteersRecruitingNCT07756853
- Perception, Sensation, Cognition and Action in HumansRecruitingNCT03407066
- National Eye Institute Biorepository for Retinal DiseasesRecruitingNCT01496625
- Rod and Cone Mediated Function in Retinal DiseaseRecruitingNCT02617966
- Screening for Research ParticipantsRecruitingNCT00655096
- Genetics of Inherited Eye DiseaseRecruitingNCT02471287
- Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma (MAC)RecruitingNCT01778543
- Natural History, Pathogenesis, and Outcome of Ocular DisordersRecruitingNCT02821767
- Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular DegenerationRecruitingNCT04339764Phase 1/2
- Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye ConditionsRecruitingNCT02077894
- Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 GeneRecruitingNCT01145196
- Cell Collection to Study Eye DiseasesRecruitingNCT01432847
- Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4RecruitingNCT04591483
- Virtual Reality Mobility Assessment of Functional Vision in Retinal DiseaseRecruitingNCT04289571Phase 1
- Adaptive Optics Retinal ImagingRecruitingNCT02317328
- Clinical and Molecular Studies in Families With Inherited Eye DiseaseRecruitingNCT02771236
- National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic DiseasesRecruitingNCT06491615
- Oral Metformin for Treatment of ABCA4 RetinopathyActive, not recruitingNCT04545736Phase 1/2
- Clinical and Genetic Studies of X-Linked Juvenile RetinoschisisCompletedNCT00055029
- Age-Related Eye Disease Study (AREDS) Follow-UpActive, not recruitingNCT00594672
- Intestinal Bacteria and Ocular Inflammatory DiseaseCompletedNCT01859299
- Study of Dark Adaptation in Age-Related Macular DegenerationCompletedNCT01352975
- Natural History of Eye Diseases Related to ABCA4 MutationsActive, not recruitingNCT01736293
- Dark Adaptation in Participants With Age-Related Macular DegenerationCompletedNCT03225131
- AMD Ryan Initiative Study (ARIS)CompletedNCT03092492
- Retinitis Pigmentosa Clinical Measures and Repeatability Testing of Potential Outcome MeasuresCompletedNCT03845218
- Potential Environmental Causes of Uveal ColobomaCompletedNCT04833361
- Natural History of Spinocerebellar Ataxia Type 7 (SCA7)Active, not recruitingNCT02741440
- Natural History of Geographic Atrophy Associated With Age-Related Macular DegenerationCompletedNCT02941263
- Uveitis/Intraocular Inflammatory Disease Biobank (iBank)CompletedNCT02656381
- Retrospective Case Series of Trans-scleral Cryotherapy for Retinal HemangioblastomaCompletedNCT04458935
- Repository for Inherited Eye DiseasesCompletedNCT00378742
- Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular DegenerationCompletedNCT02564978Phase 2
- Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark AdaptationCompletedNCT03478878Early Phase 1
- Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark AdaptationCompletedNCT03478865Early Phase 1
- The Focal Electro-Oculogram in Macular DiseaseCompletedNCT02225119
- Training to Modify Fixational Eye Movements for Optimizing Visual Performance in People With Central Vision LossActive, not recruitingNCT06670989Not applicable
- The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory DiseaseCompletedNCT00331331
- Biomarkers in Ocular Inflammation and UveitisCompletedNCT04690829
- Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis PigmentosaCompletedNCT02140164Phase 1/2
- Visual Motor CoordinationTerminatedNCT00568243
- Topical Interferon Gamma-1b for Central Serous ChorioretinopathyCompletedNCT01468337Phase 1/2
- Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous ChorioretinopathyCompletedNCT01227993Phase 1/2
- Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau SyndromeTerminatedNCT00673816Phase 1/2
- Sirolimus to Treat Diabetic Macular EdemaCompletedNCT00711490Phase 1/2
- Ranibizumab and Bevacizumab for Diabetic Macular EdemaCompletedNCT01610557Phase 2
- Ocular Findings and Viral Persistence in Ocular Fluids in COVID-19 SurvivorsTerminatedNCT04665752
- Human Samples and Data RepositoryTerminatedNCT00539370
- Minocycline to Treat Branch Retinal Vein OcclusionCompletedNCT01468831Phase 1/2
- A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist RanibizumabCompletedNCT02859441Phase 1/2